Format:
11
,
Illustrationen
ISSN:
1600-0641
Content:
Nucleos(t)ide analogues (NUCs) are the standard and mostly lifelong treatment for chronic HBeAg-negative hepatitis B, as functional cure (loss of HBsAg) is rarely achieved. Discontinuation of NUC treatment may lead to functional cure; however, to date, the evidence for this has been based on small or non-randomized clinical trials. The STOP-NUC trial was designed with the aim of increasing the HBsAg loss rate using a NUC treatment interruption approach.
Note:
Online veröffentlicht am 28. März 2023
,
Gesehen am 05.09.2023
In:
Journal of hepatology, Amsterdam [u.a.] : Elsevier Science, 1985, 78(2023), 5 vom: Mai, Seite 926-936, 1600-0641
In:
volume:78
In:
year:2023
In:
number:5
In:
month:05
In:
pages:926-936
In:
extent:11
Language:
English
DOI:
10.1016/j.jhep.2022.12.018
URL:
Volltext
(lizenzpflichtig)
Author information:
Pathil-Warth, Anita 1981-
Author information:
Bömmel, Florian van 1973-
Author information:
Cornberg, Markus 1971-
Author information:
Berg, Thomas 1963-
Author information:
Sprinzl, Martin F. 1975-
Author information:
Zeuzem, Stefan
Author information:
Stallmach, Andreas 1960-
Author information:
Schott, Eckart 1969-
Author information:
Trautwein, Christian 1940-
Author information:
Ingiliz, Patrick Philipp 1973-
Author information:
Arnim, Ulrike von 1967-
Author information:
Zipprich, Alexander
Author information:
Keitel-Anselmino, Verena 1976-
Author information:
Schulze zur Wiesch, Julian Constantin Raimar 1974-
Bookmarklink